Hi,

At our last conversation in March, my neurologist opened up the universe of MS drugs for me to choose one, including Tysabri.
That was a surprise. I had been gritting my teeth getting ready to reluctantly submit to Avonex. I took a week to think. I read trial results for Gilenya, especially the brain atrophy result and decided to add Gilenya while I can still afford health insurance. If it goes poorly I can ...

An MS Drug Takes a Feisty Approach Aimed at Younger Patients

The Swiss drug maker Novartis is taking a sassy new tack to win converts to its oral multiple sclerosis treatment, Gilenya. Its “Hey MS, Take This!” campaign shows patients sticking out their tongues with Gilenya capsules on them to show their willingness to fight back against the neurological condition..... Read More - http://www.ms-uk.org/index.cfm/MSnews

Gilenya® Demonstrates Consistent Benefits In Reduction Of Relapses And Brain Volume Loss In Relapsing-Remitting MS

Data presented at the 65th annual meeting of the American Academy of Neurology (AAN) show Gilenya® (fingolimod), the first and only once-daily oral therapy reimbursed to treat highly active relapsing-remitting multiple sclerosis (RRMS), significantly and consistently reduced the rate of brain volume loss and reduced relapse rates compared to interferon beta-1a IM or placebo.

The new data add to the ...

Novartis AG said its Gilenya drug to treat multiple sclerosis helped slow brain loss, a measure linked to the severity of the disease.

Patients taking Gilenya in three large Novartis-led studies lost a third less brain volume than patients taking either a placebo or Biogen Idec Inc. Avonex, Novartis said in an e- mailed statement today..... Read More - http://www.ms-uk.org/index.cfm/gilenya

Novartis AG said it will present new data on Multiple Sclerosis or MS treatment at the 65th annual meeting of the American Academy of Neurology or AAN.

It will highlight growing clinical trial and real-world experience with Gilenya (fingolimod), the first once-daily oral therapy approved to treat people with relapsing MS or RMS. Updates on studies of Gilenya in people with primary-progressive MS or PPMS and the investigational agent BAF312 (siponimod) in people with secondary-progressive ...

MS-UK Gilenya Diaries

Dan has sent in a new entry for his Gilenya Blog

You can read it at http://www.ms-uk.org/index.cfm/gilenyadan

It may be harder stopping fingolimod (Gilenya) than starting it
http://www.overcomingmultiplesclerosis. ... arting+it/

Neurologists from Florence in Italy have reported the histories of a series of six people with MS who had to stop fingolimod (Gilenya) treatment for MS. All commenced an alternative disease-modifying drug when stopping, however within three months of stopping, five returned to pre-treatment levels of disease activity, and one experienced a rebound, that is the ...

I took my first does of Gilenya at 8am yesterday morning. I was being monitored at a Concentra Immediate Care center. I wasn't sure what to expect, but was happy to see I wouldn't' be hooked up to a heart monitor or anything. With my anxiety, I'm sure i would have been watching that thing like a hawk! They started off with an EKG, then did checked my heart rate and blood pressure both sitting ...

Since being diagnosed I've had a varying mild-to-moderate case of ED and anorgasmia. I tried cialis and viagra to treat, and while they certainly worked, I always found it difficult to get the timing right - which just added more stress to a stressful symptom.

Since starting Gilenya, I've felt like I was on one of those two constantly. None of the headache side-effects (at least, not as sever), but both the ED and anorgasmia ...

i have been on gilenya for a month(30) days so far, I am not feeling any differences besides maybe a little more energy.

so my question is, what are some physical benefits other people are feeling?